Am J Pathol

1. GREIG A, Henrique R, Xie B, Thrasivoulou C, et al
   Super-Resolution Microscopy Reveals Alterations in Clathrin Structure in Human Cancer Tissue.
   Am J Pathol. 2025;195:1619-1626.
   

   >> Share

   
   

   
   BJU Int

2. CHONG B, Chen K
   Reply to 'A mitochondrion-centric approach to guide treatment de-escalation in advanced prostate cancer' by Su et al.
   BJU Int. 2025 Aug 22. doi: 10.1111/bju.16898.
   

   >> Share

   
   
3. CHIAM K, Bang A, Nair-Shalliker V, Caruana M, et al
   Treatment variations in localised prostate cancer in Australia and New Zealand: a registry study.
   BJU Int. 2025 Aug 22. doi: 10.1111/bju.16896.
   

   >> Share

   
   
4. ITO K, Mori K, Kumar R, Sabnis RB, et al
   Global viewpoints: evolving epidemiology and treatment patterns of prostate cancer in Asia.
   BJU Int. 2025 Aug 24. doi: 10.1111/bju.16900.
   

   >> Share

   
   
5. SU PJ, Shao IH, Lin YH
   A mitochondrion-centric approach to guide treatment de-escalation in advanced prostate cancer.
   BJU Int. 2025 Aug 22. doi: 10.1111/bju.16897.
   

   >> Share

   
   
6. FLETCHER SA, Macura KJ, Pavlovich CP
   Author response to comment on 'Clinically significant prostate cancer detected by systematic biopsy in patients with MRI lesions'.
   BJU Int. 2025 Aug 17. doi: 10.1111/bju.16869.
   

   >> Share

   
   
7. COLLINS KK, Virdee PS, Roberts N, Oke JL, et al
   Guideline of guidelines: a critical appraisal of the evidence for PSA retesting intervals.
   BJU Int. 2025;136:372-384.
   

   >> Share

   
   
8. BERRENS AC, Buckle T, van Oosterom MN, Slof LJ, et al
   Renal clearance of fluorescent agents can compromise image-guided surgery along the urinary tract.
   BJU Int. 2025;136:515-522.
   

   >> Share

   
   
9. LENI R, Tin AL, Liso N, Carlsson SV, et al
   Magnetic resonance imaging for long-term active surveillance biopsy decision-making.
   BJU Int. 2025;136:500-506.
   

   >> Share

   
   
10. LEPOR H, Persily J, Parry S, Rapoport E, et al
    Routine prostate biopsies not needed after cryotherapy if surveillance MRI is normal.
    BJU Int. 2025;136:447-451.
    

    >> Share

    
    

    
    BMC Cancer

11. DENG S, Huang D, Han X, Zhang H, et al
    A novel MRI-based habitat analysis and deep learning for predicting perineural invasion in prostate cancer: a two-center study.
    BMC Cancer. 2025;25:1367.
    

    >> Share

    
    

    
    Br J Radiol

12. HE CL, Yang T, Zhang MN, Yao J, et al
    A Novel Approach to Differentiate Prostate Cancer from Prostatitis in the Peripheral Zone.
    Br J Radiol. 2025 Aug 20:tqaf186. doi: 10.1093.
    

    >> Share

    
    

    
    Cancer

13. FALAGARIO UG, Pellegrino F, Abbadi A, Bjornebo L, et al
    Detectable prostate-specific antigen after radiotherapy for clinically localized prostate cancer.
    Cancer. 2025;131:e70045.
    

    >> Share

    
    

    
    Cancer Imaging

14. YAO F, Lin H, Xue YN, Zhuang YD, et al
    Multimodal imaging deep learning model for predicting extraprostatic extension in prostate cancer using MpMRI and 18 F-PSMA-PET/CT.
    Cancer Imaging. 2025;25:103.
    

    >> Share

    
    
15. A GLEMSER P, Netzer N, H Ziener C, Wilhelm M, et al
    Improving risk stratification of PI-RADS 3 + 1 lesions of the peripheral zone: expert lexicon of terms, multi-reader performance and contribution of artificial intelligence.
    Cancer Imaging. 2025;25:102.
    

    >> Share

    
    

    
    Cancer Res

16. VENKADAKRISHNAN VB, Presser A, Voss NCE, Neiswender J, et al
    Epigenetic De-repression of PROX1 Promotes Neuroendocrine Prostate Cancer Progression.
    Cancer Res. 2025 Aug 21. doi: 10.1158/0008-5472.CAN-25-0636.
    

    >> Share

    
    
17. HOSSEINI N, Mannan R, Rebernick RJ, Su F, et al
    Divergent Clonal Evolution and Early Dissemination Promote Genetic Heterogeneity of Metastases in Castration Resistant Prostate Cancer.
    Cancer Res. 2025 Aug 18. doi: 10.1158/0008-5472.CAN-24-3687.
    

    >> Share

    
    

    
    Cancer Treat Res

18. SINGHAL G, Garg P, Mohanty A, Kollimuttathuillam SV, et al
    Advancing Prostate Cancer Treatment: Innovations and Challenges in Immunotherapy.
    Cancer Treat Res. 2025;129:267-291.
    

    >> Share

    
    

    
    Clin Imaging

19. CHIMMULA RR, Green M, Tann M, Koch M, et al
    Comparative analysis of machine learning-derived nomogram and biomarkers in predicting side-specific extraprostatic extension: Preliminary findings.
    Clin Imaging. 2025;125:110556.
    

    >> Share

    
    

    
    Eur J Radiol

20. AGROTIS G, Woo S, Jaderling F, Ursprung S, et al
    Radiological T-staging in prostate Cancer: Towards a universal MRI-based scoring system.
    Eur J Radiol. 2025;191:112363.
    

    >> Share

    
    
21. ZHANG X, Shen H, Xu Q, Tu C, et al
    CT derived myocardial extracellular volume predict major adverse cardiovascular events in patients with prostate cancer.
    Eur J Radiol. 2025;192:112371.
    

    >> Share

    
    

    
    Eur Radiol

22. SYER T, Carmo B, Sanmugalingam N, Lawson B, et al
    On-table monitoring of prostate MRI could enable tailored utilisation of gadolinium contrast.
    Eur Radiol. 2025;35:5701-5709.
    

    >> Share

    
    
23. AGROTIS G, Ursprung S, Schoots IG
    Personalised prostate MRI: tailoring contrast medium use in an era of increasing demand.
    Eur Radiol. 2025;35:5710-5713.
    

    >> Share

    
    

    
    Eur Urol

24. LIN PH, Burwell AD, Giovannucci EL, Loeb S, et al
    Dietary Patterns in Prostate Cancer Prevention and Management: A Systematic Review of Prospective Cohort Studies and Randomized Clinical Trials.
    Eur Urol. 2025 Aug 19:S0302-2838(25)00433-6. doi: 10.1016/j.eururo.2025.
    

    >> Share

    
    
25. SCUDERI S, Gandaglia G, Briganti A, Montorsi F, et al
    Re: Prostate Cancer: A Review.
    Eur Urol. 2025 Aug 19:S0302-2838(25)00437-3. doi: 10.1016/j.eururo.2025.
    

    >> Share

    
    
26. DEMOGEOT N, Sargos P, Salleron J, Guerif S, et al
    Short-term Androgen Deprivation Therapy and High-dose Radiotherapy in Intermediate- and High-risk Localized Prostate Cancer: Results from the GETUG 14 Randomized Phase 3 Trial.
    Eur Urol. 2025 Aug 14:S0302-2838(25)00436-1. doi: 10.1016/j.eururo.2025.
    

    >> Share

    
    

    
    Int J Radiat Oncol Biol Phys

27. ONG WL, Davidson M, Wronski M, Kang T, et al
    Bowel bag dosimetric parameters for ultrahypofractionated pelvic elective nodal irradiation in prostate cancer.
    Int J Radiat Oncol Biol Phys. 2025 Aug 15:S0360-3016(25)06145.
    

    >> Share

    
    
28. SONG Y, Dornisch AM, Dess RT, Margolis DJA, et al
    Multidisciplinary Consensus Prostate Contours on Magnetic Resonance Imaging: Educational Atlas and Reference Standard for Artificial Intelligence Benchmarking.
    Int J Radiat Oncol Biol Phys. 2025;123:183-194.
    

    >> Share

    
    

    
    Int J Urol

29. YAMAMOTO Y, Fujimoto S, Hashimoto M, Minami T, et al
    Comparison of Oncological Outcomes of Conventional Androgen Deprivation Therapy (ADT) and ADT Plus Androgen Receptor Signaling Inhibitor in Older Patients With Metastatic Castration-Sensitive Prostate Cancer.
    Int J Urol. 2025 Aug 14. doi: 10.1111/iju.70202.
    

    >> Share

    
    
30. SHIMOMURA T
    Editorial Comment to "Preliminary Report on the Efficacy and Safety of Triplet Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer: YUSHIMA Study".
    Int J Urol. 2025 Aug 19. doi: 10.1111/iju.70185.
    

    >> Share

    
    
31. IWAMOTO H, Hori T, Inaba T, Nakagawa R, et al
    Prognostic Impact of Time to Castration Resistance on Overall Survival in Patients With Metastatic Castration-Sensitive Prostate Cancer.
    Int J Urol. 2025 Aug 19. doi: 10.1111/iju.70197.
    

    >> Share

    
    
32. ARAI S
    Editorial Comment on Efficacy of Docetaxel Addition to Next-Generation Androgen Receptor-Axis-Targeted Therapies and Androgen Deprivation Therapy in Metastatic Hormone-Sensitive Prostate Cancer: A Tumor Volume-Specific Analysis.
    Int J Urol. 2025 Aug 21. doi: 10.1111/iju.70208.
    

    >> Share

    
    

    
    N Engl J Med

33. EKLUND M, Thompson IM Jr, Cooperberg MR
    Screening for Prostate Cancer with a Polygenic Risk Score.
    N Engl J Med. 2025;393:831.
    

    >> Share

    
    
34. SU CY, Hasebe M
    Screening for Prostate Cancer with a Polygenic Risk Score.
    N Engl J Med. 2025;393:831.
    

    >> Share

    
    
35. GREEN HD, Jackson L, Bailey SER
    Screening for Prostate Cancer with a Polygenic Risk Score.
    N Engl J Med. 2025;393:831-832.
    

    >> Share

    
    
36. BANCROFT EK, McHugh JK, Eeles RA
    Screening for Prostate Cancer with a Polygenic Risk Score. Reply.
    N Engl J Med. 2025;393:832.
    

    >> Share

    
    

    
    Oncogene

37. TONG T, Lei H, Huang M, Yang Z, et al
    HOMER3 orchestrates SRC-YAP1 activity that promotes tumor cell growth and antagonizes anti-tumor immunotherapy in prostate cancer.
    Oncogene. 2025 Aug 23. doi: 10.1038/s41388-025-03548.
    

    >> Share

    
    

    
    Prostate

38. THILLAINADESAN G, Amemiya Y, Nam R, Seth A, et al
    Machine Learning Approach Identifies miRNA Biomarkers for Post Surgical Patient Stratification in Prostate Cancer.
    Prostate. 2025 Aug 16. doi: 10.1002/pros.70034.
    

    >> Share

    
    
39. XU K, Khan A, Evancho P, Chu M, et al
    Analysis of the Increased Incidence of Aggressive Prostate Cancer After Prior Testicular Cancer.
    Prostate. 2025 Aug 16. doi: 10.1002/pros.70035.
    

    >> Share

    
    
40. PAVLOVICH CP, Wei J, Gielzak M, Shi Z, et al
    Confirmation of BIK and SAMHD1 as Prostate Cancer Susceptibility Genes.
    Prostate. 2025 Aug 18. doi: 10.1002/pros.70037.
    

    >> Share

    
    
41. KURUCZ LM, Natali T, Westerhout S, Hagens M, et al
    Prostate Volume and PSA-Density Estimation by Transabdominal Ultrasound: Prospective Evidence of Comparative Accuracy to MRI and Transrectal Ultrasound in Prostate Cancer Early Diagnostics.
    Prostate. 2025 Aug 18. doi: 10.1002/pros.70036.
    

    >> Share

    
    

    
    Radiol Imaging Cancer

42. RODRIGUES AC, de Almeida JG, Rodrigues N, Moreno R, et al
    Improving Clinically Significant Prostate Cancer Detection with a Multimodal Machine Learning Approach: A Large-Scale Multicenter Study.
    Radiol Imaging Cancer. 2025;7:e240507.
    

    >> Share

    
    

    
    Urol Int

43. LUO H, Liao G, Liu Y
    Efficacy of Neoadjuvant Hormone Therapy Combined with Radical Prostatectomy in Improving Oncological Outcomes for Patients with cT3 Prostate Cancer: A Systematic Review and Meta-Analysis.
    Urol Int. 2025 Aug 13:1-37. doi: 10.1159/000547875.
    

    >> Share

    
    

    
    Urology

44. GARNICK MB, Kent MA
    Editorial Comment on "Prostate Specific Antigen Testing and Prostate Cancer Diagnosis Rates Among Transgender and Nonbinary Patients: Retrospective Review of a Single-Institution Experience".
    Urology. 2025 Aug 22:S0090-4295(25)00804-0. doi: 10.1016/j.urology.2025.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share